Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BioPsychoSocial Medicine
Published in: BioPsychoSocial Medicine 1/2011

Open Access 01-12-2011 | Editorial

A neurological approach to biopsychosocial medicine: Lessons from irritable bowel syndrome

Author: Shin Fukudo

Published in: BioPsychoSocial Medicine | Issue 1/2011

Login to get access

Excerpt

Modern people are still influenced by the mind-body dualism of Rene Descartes. Some of these people said "Anxiety aggravated the symptoms of these patients," a notion that most people probably consider natural. By contrast, I would like to criticize this concept because anxiety is posited as an independent driving force that actively changes one's body. However, anxiety per se is a subjective feeling produced by the brain and somatic signals from the body. Actually, neural activities in the central and autonomic nervous systems along with endocrine and immune function change the body. From this point of view, anxiety is not the CAUSE of mind-body changes but the RESULT of them. The origin and synthetic processing of emotion are more important than simple idea that the "mind" directly changes the body. Descartes' mind-body dualism conceals, in our view, how diseases should be recognized and analyzed. …
Literature
1.
Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006, 130: 1377-90. 10.1053/j.gastro.2006.03.008.CrossRefPubMed
2.
Fukudo S, Kanazawa M, Mizuno T, Hamaguchi T, Kano M, Watanabe S, Sagami Y, Shoji T, Endo Y, Hongo M, Itoyama Y, Yanai K, Tashiro M, Aoki M: Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage. 2009, 47: 946-951. 10.1016/j.neuroimage.2009.04.083.CrossRefPubMed
3.
Fukudo S: Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007, 42 (Suppl 17): 48-51. 10.1007/s00535-006-1942-7.CrossRefPubMed
4.
Fukudo S, Nomura T, Muranaka M, Taguchi F: Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. J Clin Gastroenterol. 1993, 17: 133-141. 10.1097/00004836-199309000-00009.CrossRefPubMed
5.
Silverman DHS, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA: Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997, 112: 64-72. 10.1016/S0016-5085(97)70220-8.CrossRefPubMed
6.
Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R: Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000, 118: 842-8. 10.1016/S0016-5085(00)70170-3.CrossRefPubMed
7.
Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T, IBS Club: High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan. J Clin Gastroenterol. 2008, 42: 1010-1016. 10.1097/MCG.0b013e318150d006.CrossRefPubMed
8.
Owens DM, Nelson DK, Talley NJ: The irritable bowel syndrome: Long term prognosisand the physician-patient interaction. Ann Intern Med. 1995, 122: 107-112.CrossRefPubMed
9.
Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM: Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992, 33: 825-830. 10.1136/gut.33.6.825.PubMedCentralCrossRefPubMed
10.
Spiller RC: Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med. 1999, 107 (5A): 91S-97S. 10.1016/S0002-9343(99)00086-8.CrossRefPubMed
11.
Kanazawa M, Endo Y, Whitehead WE, Kano M, Hongo M, Fukudo S: Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004, 49: 1046-53. 10.1023/B:DDAS.0000034570.52305.10.CrossRefPubMed
12.
Drossman DA, Leserman J, Nachman G, Li Z, Gluck H, Toomey TC, Mitchell CM: Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med. 1990, 113: 828-833.CrossRefPubMed
13.
Drossman DA, Ringel Y, Vogt B, Leserman J, Lin W, Smith JK, Whitehead WE: Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe IBS. Gastroenterology. 2003, 124: 754-761. 10.1053/gast.2003.50103.CrossRefPubMed
14.
Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO: Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev. 2009, CD006442-1
15.
Whorwell PJ, Prior A, Faragher EB: Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet. 1984, 2: 1232-1233. 10.1016/S0140-6736(84)92793-4.CrossRefPubMed
16.
Shinozaki M, Kanazawa M, Kano M, Endo Y, Nakaya N, Hongo M, Fukudo S: Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2010, 35: 189-198. 10.1007/s10484-009-9125-y.CrossRefPubMed
17.
Drossman DA, Toner BB, Whitehead WE, Diamant NE, Dalton CB, Duncan S, Emmott S, Proffitt V, Akman D, Frusciante K, Le T, Meyer K, Bradshaw B, Mikula K, Morris CB, Blackman CJ, Hu Y, Jia H, Li Z, Koch GG, Bangdiwala SI: Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003, 125: 19-31. 10.1016/S0016-5085(03)00669-3.CrossRefPubMed
18.
Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC: Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 1997, 277: 968-71. 10.1126/science.277.5328.968.CrossRefPubMed
19.
Singer T, Seymour B, O'Doherty J, Kaube H, Dolan RJ, Frith CD: Empathy for pain involves the affective but not sensory components of pain. Science. 2004, 303: 1157-62. 10.1126/science.1093535.CrossRefPubMed
Metadata
Title
A neurological approach to biopsychosocial medicine: Lessons from irritable bowel syndrome
Author
Shin Fukudo
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BioPsychoSocial Medicine / Issue 1/2011
Electronic ISSN: 1751-0759
DOI
https://doi.org/10.1186/1751-0759-5-1

Other articles of this Issue 1/2011

BioPsychoSocial Medicine 1/2011 Go to the issue

Research

A before and after comparison of the effects of forest walking on the sleep of a community-based sample of people with sleep complaints

Short report

Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study

Research

Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations

Research

Profile of mood states and stress-related biochemical indices in long-term yoga practitioners

Research

Does sleep aggravate tension-type headache?: An investigation using computerized ecological momentary assessment and actigraphy

Research

The longitudinal BMI pattern and body composition of patients with anorexia nervosa who require urgent hospitalization: A case control study